Duodenal microbiota and weight-loss following sleeve gastrectomy and Roux-en-Y gastric bypass - a pilot study

BMC Surg. 2023 Jun 26;23(1):173. doi: 10.1186/s12893-023-02076-6.

Abstract

Background: Bariatric surgery is the most effective method of morbid obesity treatment. Microbiota has many functions in human body and many of them remain to be unknown. The aim of this study was to establish if the composition of duodenal microbiota influences success rate of bariatric surgery.

Methods: It was a prospective cohort study. The data concerning demographics and comorbidities was collected perioperatively. The duodenal biopsies were collected prior to surgery with the gastroscope. Then DNA analysis was conducted. The data connected to the operation outcomes was gathered after 6 and 12 months after surgery.

Results: Overall, 32 patients were included and divided into two groups (successful - group 1 and unsuccessful - group 0) based on percentage excess weight loss after 6 months were created. The Total Actual Abundance was higher in group 0. In group 0 there was a significantly higher amount of Roseburia and Arthrobacter (p = 0.024, p = 0.027, respectively). Genus LDA effect size analysis showed Prevotella, Megasphaera and Pseudorhodobacter in group 1 to be significant. Whereas abundance of Roseburia and Arthrobacter were significant in group 0.

Conclusions: Duodenal microbiota composition may be a prognostic factor for the success of the bariatric surgery but further research on the larger group is needed.

Keywords: Bariatric surgery; Microbiota; Obesity; Sleeve gastrectomy.

MeSH terms

  • Gastrectomy / methods
  • Gastric Bypass* / methods
  • Humans
  • Laparoscopy* / methods
  • Microbiota*
  • Obesity, Morbid* / surgery
  • Pilot Projects
  • Prospective Studies
  • Retrospective Studies
  • Treatment Outcome
  • Weight Loss